Companies House 09613254 2024-10-31 2024-10-31 2023-11-01 false iso4217:GBP xbrli:pure 09613254 2022-11-01 2023-10-31 09613254 2024-10-31 09613254 2023-11-01 2024-10-31 09613254 2023-10-31 09613254 curr:PoundSterling 2023-11-01 2024-10-31 09613254 uk-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 09613254 uk-bus:FRS102 2023-11-01 2024-10-31 09613254 uk-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 09613254 uk-bus:FullAccounts 2023-11-01 2024-10-31 09613254 uk-bus:RegisteredOffice 2023-11-01 2024-10-31 09613254 uk-bus:Director1 2023-11-01 2024-10-31 09613254 uk-bus:Director2 2023-11-01 2024-10-31 09613254 uk-bus:Director3 2023-11-01 2024-10-31 09613254 uk-bus:Director4 2023-11-01 2024-10-31 09613254 uk-bus:Director5 2023-11-01 2024-10-31 09613254 uk-bus:Director6 2023-11-01 2024-10-31 09613254 uk-bus:Director7 2023-11-01 2024-10-31 09613254 uk-bus:Director8 2023-11-01 2024-10-31 09613254 uk-bus:Director9 2023-11-01 2024-10-31 09613254 uk-bus:Director10 2023-11-01 2024-10-31 09613254 uk-bus:Director11 2023-11-01 2024-10-31 09613254 uk-bus:Director12 2023-11-01 2024-10-31 09613254 uk-bus:Director13 2023-11-01 2024-10-31 09613254 uk-bus:Director14 2023-11-01 2024-10-31 09613254 uk-bus:Director15 2023-11-01 2024-10-31 09613254 uk-bus:Director16 2023-11-01 2024-10-31 09613254 uk-bus:Director17 2023-11-01 2024-10-31 09613254 uk-bus:Director18 2023-11-01 2024-10-31 09613254 uk-bus:Director19 2023-11-01 2024-10-31 09613254 uk-bus:Director20 2023-11-01 2024-10-31 09613254 uk-bus:Director21 2023-11-01 2024-10-31 09613254 uk-bus:CompanySecretary1 2023-11-01 2024-10-31 09613254 core:AfterOneYear 2024-10-31 09613254 core:AfterOneYear 2023-10-31 09613254 core:WithinOneYear 2024-10-31 09613254 core:WithinOneYear 2023-10-31 09613254 core:WithinOneYear 2023-11-01 2024-10-31 09613254 core:AfterOneYear 2024-10-31 09613254 core:AfterOneYear 2023-10-31 09613254 core:AfterOneYear 2023-11-01 2024-10-31 09613254 core:ShareCapital 2024-10-31 09613254 core:ShareCapital 2023-10-31 09613254 core:SharePremium 2024-10-31 09613254 core:SharePremium 2023-10-31 09613254 core:OtherReservesSubtotal 2024-10-31 09613254 core:OtherReservesSubtotal 2023-10-31 09613254 core:RevaluationReserve 2024-10-31 09613254 core:RevaluationReserve 2023-10-31 09613254 core:RetainedEarningsAccumulatedLosses 2024-10-31 09613254 core:RetainedEarningsAccumulatedLosses 2023-10-31 09613254 1 2023-11-01 2024-10-31 09613254 2 2023-11-01 2024-10-31 09613254 3 2023-11-01 2024-10-31 09613254 core:LandBuildings 2023-11-01 2024-10-31 09613254 core:LandBuildings 2024-10-31 09613254 core:LandBuildings 2022-11-01 2023-10-31 09613254 core:LandBuildings 2023-10-31 09613254 core:PlantMachinery 2023-11-01 2024-10-31 09613254 core:PlantMachinery 2024-10-31 09613254 core:PlantMachinery 2022-11-01 2023-10-31 09613254 core:PlantMachinery 2023-10-31 09613254 core:FurnitureFittingsToolsEquipment 2023-11-01 2024-10-31 09613254 core:FurnitureFittingsToolsEquipment 2024-10-31 09613254 core:FurnitureFittingsToolsEquipment 2022-11-01 2023-10-31 09613254 core:FurnitureFittingsToolsEquipment 2023-10-31 09613254 core:OfficeEquipment 2023-11-01 2024-10-31 09613254 core:OfficeEquipment 2024-10-31 09613254 core:OfficeEquipment 2022-11-01 2023-10-31 09613254 core:OfficeEquipment 2023-10-31 09613254 core:Vehicles 2023-11-01 2024-10-31 09613254 core:Vehicles 2024-10-31 09613254 core:Vehicles 2022-11-01 2023-10-31 09613254 core:Vehicles 2023-10-31 09613254 core:NetGoodwill 2023-11-01 2024-10-31 09613254 core:NetGoodwill 2024-10-31 09613254 core:NetGoodwill 2022-11-01 2023-10-31 09613254 core:NetGoodwill 2023-10-31 09613254 core:IntangibleAssetsOtherThanGoodwill 2023-11-01 2024-10-31 09613254 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 09613254 core:IntangibleAssetsOtherThanGoodwill 2022-11-01 2023-10-31 09613254 core:IntangibleAssetsOtherThanGoodwill 2023-10-31

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Company Registration Number:
09613254 (England and Wales)

## Unaudited statutory accounts for the year ended 31 October 2024

## Period of accounts

## Start date: 1 November 2023

## End date: 31 October 2024

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Contents of the Financial Statements

for the Period Ended 31 October 2024

Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Profit And Loss Account

for the Period Ended 31 October 2024

| 2024 | 2023
--- | --- | ---
| £ | £
Turnover: | 0 | 1,034
Cost of sales: | 0 | 0
Gross profit(or loss): | 0 | 1,034
Distribution costs: | 0 | 0
Administrative expenses: | ( 53 ) | ( 33,130 )
Other operating income: | 0 | 0
Operating profit(or loss): | (53) | (32,096)
Interest receivable and similar income: | 0 | 0
Interest payable and similar charges: | 0 | 0
Profit(or loss) before tax: | (53) | (32,096)
Tax: | 0 | ( 32,376 )
Profit(or loss) for the financial year: | (53) | (64,472)

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Balance sheet

As at 31 October 2024

| Notes | 2024 | 2023
--- | --- | --- | ---
|  | £ | £
Called up share capital not paid: |  | 1 | 1
Fixed assets
Intangible assets: |  | 0 | 0
Tangible assets: | 3 | 0 | 362
Investments: |  | 0 | 0
Total fixed assets: |  | 0 | 362
Current assets
Stocks: |  | 0 | 0
Debtors: |  | 0 | 0
Cash at bank and in hand: |  | 0 | 3,272
Investments: |  | 0 | 0
Total current assets: |  | 0 | 3,272
Prepayments and accrued income: |  | 53 | 0
Creditors: amounts falling due within one year: | 4 | ( 53 ) | ( 17,581 )
Net current assets (liabilities): |  | 0 | (14,309)
Total assets less current liabilities: |  | 1 | ( 13,946)
Creditors: amounts falling due after more than one year: | 5 | ( 53 ) | ( 10,575 )
Provision for liabilities: |  | 0 | 0
Accruals and deferred income: |  | 0 | ( 2,704 )
Total net assets (liabilities): |  | (52) | (27,225)
Capital and reserves
Called up share capital: |  | 1 | 1
Share premium account: |  | 0 | 0
Other reserves: |  | 0 | 0
Profit and loss account: |  | (53 ) | (27,226 )
Total Shareholders' funds: |  | ( 52 ) | (27,225)

The notes form part of these financial statements

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Balance sheet statements

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 3 January 2026
and signed on behalf of the board by:

Name: Gareth Presch
Status: Director

The notes form part of these financial statements

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Notes to the Financial Statements

for the Period Ended 31 October 2024

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover represents the total income received by the company from its ordinary activities during the financial year. For the purposes of these accounts, turnover is measured at the fair value of the consideration received or receivable, excluding any VAT or other sales taxes. No income has been accrued that is not yet received.

  Tangible fixed assets depreciation policy

  Depreciation is provided on tangible fixed assets to write off the cost, less estimated residual value, of each asset over its expected useful life. Depreciation is charged on a straight-line basis. For micro-entity purposes, only assets of material value are depreciated. Small value assets may be expensed in the year of purchase.

  Intangible fixed assets amortisation policy

  Amortisation is provided on intangible fixed assets to write off the cost, less any residual value, of each asset over its estimated useful life. Amortisation is charged on a straight-line basis. For micro-entity purposes, only assets of material value are amortised. Small value intangible assets may be expensed in the year of purchase.

  Valuation information and policy

  The company’s assets and liabilities have been measured at historical cost. No revaluations have been made during the financial year. This is consistent with the provisions applicable to small companies under FRS 102 Section 1A (Small Entities).

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Notes to the Financial Statements

for the Period Ended 31 October 2024

- ## 2. Employees

  | 2024 | 2023
  --- | --- | ---
  Average number of employees during the period | 1 | 1

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
At 1 November 2023 | 0 | 0 | 362 | 0 | 0 | 362
Additions | 0 | 0 | 0 | 0 | 0 | 0
Disposals | 0 | 0 | ( 362 ) | 0 | 0 | ( 362 )
Revaluations | 0 | 0 | 0 | 0 | 0 | 0
Transfers | 0 | 0 | 0 | 0 | 0 | 0
At 31 October 2024 | 0 | 0 | 0 | 0 | 0 | 0
Depreciation |  |  |  |  |  |
At 1 November 2023 | 0 | 0 | 0 | 0 | 0 | 0
Charge for year | 0 | 0 | 0 | 0 | 0 | 0
On disposals | 0 | 0 | 0 | 0 | 0 | 0
Other adjustments | 0 | 0 | 0 | 0 | 0 | 0
At 31 October 2024 | 0 | 0 | 0 | 0 | 0 | 0
Net book value |  |  |  |  |  |
At 31 October 2024 | 0 | 0 | 0 | 0 | 0 | 0
At 31 October 2023 | 0 | 0 | 362 | 0 | 0 | 362

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 4. Creditors: amounts falling due within one year note

| 2024 | 2023
--- | --- | ---
| £ | £
Bank loans and overdrafts | 53 | 0
Amounts due under finance leases and hire purchase contracts | 0 | 0
Trade creditors | 0 | 0
Taxation and social security | 0 | 0
Accruals and deferred income | 0 | 0
Other creditors | 0 | 17,581
Total | 53 | 17,581

# WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 5. Creditors: amounts falling due after more than one year note

| 2024 | 2023
--- | --- | ---
| £ | £
Bank loans and overdrafts | 53 | 0
Amounts due under finance leases and hire purchase contracts | 0 | 0
Other creditors | 0 | 10,575
Total | 53 | 10,575

The company has no creditors falling due after more than one year as at 31 October 2024.

# COMMUNITY INTEREST ANNUAL REPORT

### WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY

### Company Number: 09613254 (England and Wales)

### Year Ending: 31 October 2024

Company activities and impact

CIC REPORT WORLD HEALTH INNOVATION SUMMIT COMMUNITY INTEREST COMPANY Company number: 09613254 The directors confirm that the company has operated in accordance with its community interest statement during the year ended 31 October 2024. The company continued its activities to promote health innovation, collaboration, and knowledge exchange to improve health and wellbeing outcomes in line with its stated community purpose. Any deficit incurred during the year has been managed responsibly, and the company remains committed to delivering community benefit. Signed on behalf of the Board: Gareth Presch Director Date: 3/01/2026

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
3 January 2026

And signed on behalf of the board by:
Name: Gareth Presch
Status: Director